Davion Healthcare Appoints Vienna Capital for Financing
Health
Acquisition
IPO:
Oct 22, 2026
Industry:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Show Chart?
Load external content from TradingView!
*You can change or withdraw your consent at any time in the footer under Cookies.
Davion Healthcare Appoints Vienna Capital Partners for US$100 Million Acquisition Financing Strategy
New York, USA - Davion Healthcare Plc (NASDAQ: DAVI) announced that it has entered into a non-exclusive financial advisory agreement with New York-based financial services firm Vienna Capital Partners LLC. The partnership aims to support Davion's proposed US$100 million-plus acquisition financing strategy throughout 2027.
... Read on — Members only
About DAVION HEALTHCARE PLC
Davion Healthcare Plc was originally incorporated in Cyprus as a public limited company on November 29, 2022 and subsequently re-domiciled its company headquarters to Ireland in September 2024, maintaining an operation in Cyprus through our wholly owned subsidiary, Davion Healthcare Ltd. We moved the company from Cyprus to Ireland within the European Union community, where it can more easily focus on developing its range of home tests for a range of home test products, to identify potential medical conditions and provide early warning to enable further clinical examination where applicable.
The Company uses third party research and development (Universities and specialized companies) together with outsourced manufacturing and design, to make products, which are then patented (where applicable), manufactured, sold and internationally distributed through licensing agreements.
